Molecular and Cellular Biology Core supports CEZID research
Official title: Molecular and Cellular Biology (MCB) Core
Funded at Kansas State University · NIH-11336280 · Data updated 2026-11-12
This grant funds a core facility at Kansas State University that provides advanced biology technologies to help researchers study emerging and zoonotic infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kansas State University NIH-funded |
| Lab location | 1 site (Manhattan, United States) |
| Project start | June 1, 2020 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $248,927 |
| NIH project number | 2P20GM130448-06 |
| Project ID | NIH-11336280 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians affiliated with CEZID conducting infectious disease and zoonotic studies.
✕Less likely to help
Direct patient participation is not part of this core grant; benefits accrue through enhanced research outputs.
What this research studies
The MCB Core at KSU supplies high-end tools and expertise to CEZID researchers, strengthening their ability to generate impactful results. It offers services like flow cytometry, next-generation sequencing, single-cell gene expression profiling, CRISPR editing, and spatial transcriptomics. In Phase 1, the core processed thousands of sequencing samples and supported numerous hours of imaging and cell analysis, contributing to many publications and grant applications. Phase 2 aims to expand capabilities and broaden user engagement to further boost NIH funding competitiveness.
Why it matters
Potential benefit: Patients could benefit indirectly from faster, better-quality infectious disease research enabled by the core’s advanced technologies.
How similar studies have gone: Earlier core facilities with advanced technologies have accelerated publications and funding success for infectious disease research.
Where this research is happening
-
Kansas State University
Manhattan, United States Active
Researchers
- Principal investigator: Mwangi, Waithaka — Kansas State University
- Study coordinator: Mwangi, Waithaka
Related research
Other NIH-funded projects on the same topics.
-
Pain relief research for food animals (models to test analgesics)
Researchers are developing reliable ways to test pain relief drugs for pigs, calves, and goats to help farmers keep animals comfortable.
-
Noninvasive brain stimulation to reduce hyperexcitability in a Fragile X rat model
A small animal study tests whether low-frequency rTMS can calm overactive brain activity and improve thinking-style tasks in a rat model of Fragile X and autism.
-
Automated nucleic acid quality checks for veterinary diagnostics
A Kansas State University lab is buying and using an automated TapeStation to quickly and reliably check the quality of RNA and DNA before dog, horse, and cattle tests.
-
Integrated microbiome and resistome framework to prevent surgical site infections in veterinary orthopedic surgery
A veterinary research project will study how preoperative microbes and resistance genes in animals relate to post-surgical infections and antibiotic failures.
-
Automated sample prep for faster plasma and feed analysis in targeted LC-MS/MS
This grant aims to speed up lab workflows by using automated liquid handling to prepare plasma and feed samples for targeted LC-MS/MS testing, helping labs process more tests with less variability.
-
Whole genome sequencing of E. coli and Salmonella from animals to improve health insights
Researchers will sequence 200 bacterial isolates from companion and food animals to better understand strains linked to human and animal health.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.